Conjunctivitis other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| (10 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Conjunctivitis}} | {{Conjunctivitis}} | ||
{{CMG}} {{AE}} | {{CMG}}; {{AE}} {{SaraM}} | ||
==Overview== | |||
There are no other imaging findings associated with conjunctivitis. However, dynamic meibomian imaging (DMI) can be used to obtain a distinct picture of the entire everted inferior [[tarsal plate]] in a patient with [[keratoconjunctivitis sicca|keratoconjunctivitis sicca (dry eye syndrome]]).<ref name="pmid24696045">{{cite journal| author=Qazi Y, Aggarwal S, Hamrah P| title=Image-guided evaluation and monitoring of treatment response in patients with dry eye disease. | journal=Graefes Arch Clin Exp Ophthalmol | year= 2014 | volume= 252 | issue= 6 | pages= 857-72 | pmid=24696045 | doi=10.1007/s00417-014-2618-2 | pmc=4038672 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24696045 }} </ref><ref name="pmid21450917">{{cite journal| author=Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 1994-2005 | pmid=21450917 | doi=10.1167/iovs.10-6997e | pmc=3072161 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450917 }} </ref> | |||
== | ==Other Imaging Findings== | ||
There are no other imaging findings associated with conjunctivitis. However, dynamic meibomian imaging (DMI) can be used in a patient with [[keratoconjunctivitis sicca|keratoconjunctivitis sicca (dry eye syndrome]])<ref name="pmid21450917">{{cite journal| author=Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 1994-2005 | pmid=21450917 | doi=10.1167/iovs.10-6997e | pmc=3072161 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450917 }} </ref> | |||
<ref name="pmid24150468">{{cite journal| author=Azari AA, Barney NP| title=Conjunctivitis: a systematic review of diagnosis and treatment. | journal=JAMA | year= 2013 | volume= 310 | issue= 16 | pages= 1721-9 | pmid=24150468 | doi=10.1001/jama.2013.280318 | pmc=4049531 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24150468 }} </ref> | |||
===Kertoconjunctivitis Sicca=== | ===Kertoconjunctivitis Sicca=== | ||
====Dynamic Meibomian Imaging==== | ====Dynamic Meibomian Imaging==== | ||
Dynamic meibomian imaging (DMI) provides a distinct picture of the entire everted inferior [[tarsal plate]], allowing both the clinician and the patient to assess the extent of | Dynamic meibomian imaging (DMI) provides a distinct picture of the entire everted inferior [[tarsal plate]], allowing both the clinician and the patient to assess the extent of meibomian gland dysfunction.<ref name="pmid24696045">{{cite journal| author=Qazi Y, Aggarwal S, Hamrah P| title=Image-guided evaluation and monitoring of treatment response in patients with dry eye disease. | journal=Graefes Arch Clin Exp Ophthalmol | year= 2014 | volume= 252 | issue= 6 | pages= 857-72 | pmid=24696045 | doi=10.1007/s00417-014-2618-2 | pmc=4038672 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24696045 }} </ref><ref name="pmid21450917">{{cite journal| author=Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK| title=The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. | journal=Invest Ophthalmol Vis Sci | year= 2011 | volume= 52 | issue= 4 | pages= 1994-2005 | pmid=21450917 | doi=10.1167/iovs.10-6997e | pmc=3072161 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21450917 }} </ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WS}} | |||
{{WH}} | |||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
[[Category: | [[Category:Immunology]] | ||
[[Category:Rheumatology]] | |||
[[Category:FinalQCRequired]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Latest revision as of 21:07, 29 July 2020
|
Conjunctivitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Conjunctivitis other imaging findings On the Web |
|
American Roentgen Ray Society Images of Conjunctivitis other imaging findings |
|
Risk calculators and risk factors for Conjunctivitis other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
There are no other imaging findings associated with conjunctivitis. However, dynamic meibomian imaging (DMI) can be used to obtain a distinct picture of the entire everted inferior tarsal plate in a patient with keratoconjunctivitis sicca (dry eye syndrome).[1][2]
Other Imaging Findings
There are no other imaging findings associated with conjunctivitis. However, dynamic meibomian imaging (DMI) can be used in a patient with keratoconjunctivitis sicca (dry eye syndrome)[2] [3]
Kertoconjunctivitis Sicca
Dynamic Meibomian Imaging
Dynamic meibomian imaging (DMI) provides a distinct picture of the entire everted inferior tarsal plate, allowing both the clinician and the patient to assess the extent of meibomian gland dysfunction.[1][2]
References
- ↑ 1.0 1.1 Qazi Y, Aggarwal S, Hamrah P (2014). "Image-guided evaluation and monitoring of treatment response in patients with dry eye disease". Graefes Arch Clin Exp Ophthalmol. 252 (6): 857–72. doi:10.1007/s00417-014-2618-2. PMC 4038672. PMID 24696045.
- ↑ 2.0 2.1 2.2 Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK (2011). "The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD". Invest Ophthalmol Vis Sci. 52 (4): 1994–2005. doi:10.1167/iovs.10-6997e. PMC 3072161. PMID 21450917.
- ↑ Azari AA, Barney NP (2013). "Conjunctivitis: a systematic review of diagnosis and treatment". JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.